The new ICH E6(R3) GCP guideline, impacting clinical studies starting 23 July 2025, introduces significantly more detailed requirements around the integrity and governance of data assets and trial records, including biospecimens, their derivatives, and all associated clinical and assay data generated during trials.
To help precision medicine teams ensure they meet these new requirements, we have developed this compliance checklist. Using QuartzBio’s Precision Medicine AI Agent Platform, with our solutions for Sample Intelligence and Biomarker Intelligence, can help you implement these checklist items and ensure compliance by July.
Check each completed item, get your score below, and contact us for next steps:
Your Readiness Score: 0 of 16
What’s your score? Rate your readiness:
0-5: Still using spreadsheets and emails? It’s not too late – QuartzBio’s technology can make digital transformation easy, accurate and fast.
6-11: You most likely have an ecosystem of point solutions to manage your data assets, but it can be a headache to ensure all these solutions are compliant. Let’s connect your point solutions across the precision medicine value chain for a scalable, platform approach to compliance.
12-16: Congratulations, you have a strong foundation of data integrity and governance! You’re ready to optimize risk-based management, leveraging insights across clinical programs, including from closed studies. Learn how QuartzBio’s platform accelerates your data-to-insights lifecycle by 2X or more.
Get in touch for personalized recommendations and a demo of our Precision Medicine AI Agent Platform:
https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg00Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-05-23 11:10:552025-05-23 11:10:55What’s your ICH E6(R3) Readiness Score?
Time-saving global filters: Instead of applying the same filters across multiple charts in a dashboard, you can now apply dashboard-level common filters, and all visualizations will instantly reflect your filtered dataset.
Improve collaboration and onboarding with organizational sharing: New “share with all” functionality enables organization-level permissions. New users can access dashboards as soon as they log in.
Visualization engine enhancements:
Statistical tests, including parametric and nonparametric tests, for richer biomarker data analysis / visualization (Figure 1)
Sample testing status heatmap for rapid insights (Figure 2)
Figure 1. Statistical tests are now available, including statistical tests for boxplots: Compare boxplots within a series to determine if their mean difference is statistically significant.
Figure 2. Sample status heatmaps added as visualization options. Gain rapid insights into multiple sample statuses to track sample collection or testing, as part of our Sample Intelligence Solution.
American Society for Clinical Oncology 2025 Annual Meeting
May 30 – June 3 (Exhibits May 30 – June 2) | McCormick Place, Chicago IL
Meet QuartzBio’s team of experts at this year’s annual ASCO meeting! See firsthand how AI agents designed for cancer research can accelerate oncology R&D and help teams like yours:
Increase your data-to-insights speed by 2X for faster study close
Increase R&D output by ≥25%
Streamline decision-making with autonomous support
Our team will be stationed in the Precision for Medicine Booth (#11059), use the button below to book a 1:1 meeting:
